|Last Price$73.39||Day Change (%)0%|
|Open Price$73.74||Day Change ($)0.00|
|Day Range73.19–73.97||52-Week Range59.20–79.37|
As of Mon 09/15/2014 03:59 PM EST | USD
Fitch Affirms AmerisourceBergen at 'A-'; Outlook Stable
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
In a fully valued market, there are worse things than buying wide-moat names at decent discounts.
We believe its acquisition strategy puts the PBM on the right course.
Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...
Despite full valuations overall, we do see some opportunities, especially in pharmacy benefit managers.
In a market leaning toward the overvalued side, stock-picking is key, and opportunities can still be found.